Cargando…

High Emergence of Multidrug-Resistant Sequence Type 131 Subclade C2 among Extended-Spectrum β-Lactamase (ESBL)-Producing Escherichia coli Isolated from the University Hospital Bratislava, Slovakia

The expansion of sequence type 131 (ST131) extended-spectrum β-lactamase (ESBL)-producing Escherichia coli (E. coli) represents major worldwide challenges. E. coli strains originating from healthcare facilities (labeled No. 1 and No. 2) of the University Hospital Bratislava (UHB) were analyzed for S...

Descripción completa

Detalles Bibliográficos
Autores principales: Koreň, Ján, Andrezál, Michal, Ozaee, Elham, Drahovská, Hana, Wawruch, Martin, Liptáková, Adriána, Maliar, Tibor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376107/
https://www.ncbi.nlm.nih.gov/pubmed/37508305
http://dx.doi.org/10.3390/antibiotics12071209
_version_ 1785079188946944000
author Koreň, Ján
Andrezál, Michal
Ozaee, Elham
Drahovská, Hana
Wawruch, Martin
Liptáková, Adriána
Maliar, Tibor
author_facet Koreň, Ján
Andrezál, Michal
Ozaee, Elham
Drahovská, Hana
Wawruch, Martin
Liptáková, Adriána
Maliar, Tibor
author_sort Koreň, Ján
collection PubMed
description The expansion of sequence type 131 (ST131) extended-spectrum β-lactamase (ESBL)-producing Escherichia coli (E. coli) represents major worldwide challenges. E. coli strains originating from healthcare facilities (labeled No. 1 and No. 2) of the University Hospital Bratislava (UHB) were analyzed for ST131 emergence, including its (sub)lineages and clonal relatedness. Antimicrobial resistance was determined in most strains. Of a total of 354 E. coli strains, 263 (74.3%) belonged to ST131; of these, 177 (67.3%) were from No. 1. Generally, among 260 ST131 E. coli, clades A/B were confirmed in 20 (7.7%), while clade C was noted in 240 (92.3%) strains; within them, subclades were detected as follows: C0 (17; 7.1%), C1 (3; 1.2%), and C2 (220; 91.7%). Among fifteen randomly selected E. coli strains that were investigated for ST and clonal relatedness, seven STs were identified: eight (53.3%) ST131, two (13.3%) ST73, and one each (6.7%) of ST10, ST12, ST14, ST1193, and ST1196. From No. 1, two ST131 in the first internal clinic and one ST131 from No. 2 in the aftercare department were highly clonally related, suggesting possible epidemiological association. Antimicrobial resistance was as follows: ciprofloxacin 93.8%, ceftazidime 78.4%, meropenem 0%, fosfomycin 2.9% and nitrofurantoin 1.4%. Prevention of ESBL-producing E. coli dissemination, especially for ST131 clade C2, is inevitably necessary for reducing drug resistance and decreasing healthcare-associated infections.
format Online
Article
Text
id pubmed-10376107
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103761072023-07-29 High Emergence of Multidrug-Resistant Sequence Type 131 Subclade C2 among Extended-Spectrum β-Lactamase (ESBL)-Producing Escherichia coli Isolated from the University Hospital Bratislava, Slovakia Koreň, Ján Andrezál, Michal Ozaee, Elham Drahovská, Hana Wawruch, Martin Liptáková, Adriána Maliar, Tibor Antibiotics (Basel) Article The expansion of sequence type 131 (ST131) extended-spectrum β-lactamase (ESBL)-producing Escherichia coli (E. coli) represents major worldwide challenges. E. coli strains originating from healthcare facilities (labeled No. 1 and No. 2) of the University Hospital Bratislava (UHB) were analyzed for ST131 emergence, including its (sub)lineages and clonal relatedness. Antimicrobial resistance was determined in most strains. Of a total of 354 E. coli strains, 263 (74.3%) belonged to ST131; of these, 177 (67.3%) were from No. 1. Generally, among 260 ST131 E. coli, clades A/B were confirmed in 20 (7.7%), while clade C was noted in 240 (92.3%) strains; within them, subclades were detected as follows: C0 (17; 7.1%), C1 (3; 1.2%), and C2 (220; 91.7%). Among fifteen randomly selected E. coli strains that were investigated for ST and clonal relatedness, seven STs were identified: eight (53.3%) ST131, two (13.3%) ST73, and one each (6.7%) of ST10, ST12, ST14, ST1193, and ST1196. From No. 1, two ST131 in the first internal clinic and one ST131 from No. 2 in the aftercare department were highly clonally related, suggesting possible epidemiological association. Antimicrobial resistance was as follows: ciprofloxacin 93.8%, ceftazidime 78.4%, meropenem 0%, fosfomycin 2.9% and nitrofurantoin 1.4%. Prevention of ESBL-producing E. coli dissemination, especially for ST131 clade C2, is inevitably necessary for reducing drug resistance and decreasing healthcare-associated infections. MDPI 2023-07-20 /pmc/articles/PMC10376107/ /pubmed/37508305 http://dx.doi.org/10.3390/antibiotics12071209 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Koreň, Ján
Andrezál, Michal
Ozaee, Elham
Drahovská, Hana
Wawruch, Martin
Liptáková, Adriána
Maliar, Tibor
High Emergence of Multidrug-Resistant Sequence Type 131 Subclade C2 among Extended-Spectrum β-Lactamase (ESBL)-Producing Escherichia coli Isolated from the University Hospital Bratislava, Slovakia
title High Emergence of Multidrug-Resistant Sequence Type 131 Subclade C2 among Extended-Spectrum β-Lactamase (ESBL)-Producing Escherichia coli Isolated from the University Hospital Bratislava, Slovakia
title_full High Emergence of Multidrug-Resistant Sequence Type 131 Subclade C2 among Extended-Spectrum β-Lactamase (ESBL)-Producing Escherichia coli Isolated from the University Hospital Bratislava, Slovakia
title_fullStr High Emergence of Multidrug-Resistant Sequence Type 131 Subclade C2 among Extended-Spectrum β-Lactamase (ESBL)-Producing Escherichia coli Isolated from the University Hospital Bratislava, Slovakia
title_full_unstemmed High Emergence of Multidrug-Resistant Sequence Type 131 Subclade C2 among Extended-Spectrum β-Lactamase (ESBL)-Producing Escherichia coli Isolated from the University Hospital Bratislava, Slovakia
title_short High Emergence of Multidrug-Resistant Sequence Type 131 Subclade C2 among Extended-Spectrum β-Lactamase (ESBL)-Producing Escherichia coli Isolated from the University Hospital Bratislava, Slovakia
title_sort high emergence of multidrug-resistant sequence type 131 subclade c2 among extended-spectrum β-lactamase (esbl)-producing escherichia coli isolated from the university hospital bratislava, slovakia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376107/
https://www.ncbi.nlm.nih.gov/pubmed/37508305
http://dx.doi.org/10.3390/antibiotics12071209
work_keys_str_mv AT korenjan highemergenceofmultidrugresistantsequencetype131subcladec2amongextendedspectrumblactamaseesblproducingescherichiacoliisolatedfromtheuniversityhospitalbratislavaslovakia
AT andrezalmichal highemergenceofmultidrugresistantsequencetype131subcladec2amongextendedspectrumblactamaseesblproducingescherichiacoliisolatedfromtheuniversityhospitalbratislavaslovakia
AT ozaeeelham highemergenceofmultidrugresistantsequencetype131subcladec2amongextendedspectrumblactamaseesblproducingescherichiacoliisolatedfromtheuniversityhospitalbratislavaslovakia
AT drahovskahana highemergenceofmultidrugresistantsequencetype131subcladec2amongextendedspectrumblactamaseesblproducingescherichiacoliisolatedfromtheuniversityhospitalbratislavaslovakia
AT wawruchmartin highemergenceofmultidrugresistantsequencetype131subcladec2amongextendedspectrumblactamaseesblproducingescherichiacoliisolatedfromtheuniversityhospitalbratislavaslovakia
AT liptakovaadriana highemergenceofmultidrugresistantsequencetype131subcladec2amongextendedspectrumblactamaseesblproducingescherichiacoliisolatedfromtheuniversityhospitalbratislavaslovakia
AT maliartibor highemergenceofmultidrugresistantsequencetype131subcladec2amongextendedspectrumblactamaseesblproducingescherichiacoliisolatedfromtheuniversityhospitalbratislavaslovakia